# GSK plc: Form 20-F/A for the period ended Dec 31, 2017

- Company: [GSK plc](/companies/gsk.md) (CIK 1131399)
- Form: 20-F/A
- Filed: 2018-03-20
- Accepted by EDGAR: Mar 20, 2018, 11:13 ET
- Period: 2017-12-31
- Accession: 0001193125-18-088407
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1131399/000119312518088407/d516109d20fa.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1131399/000119312518088407/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2017-01-01 to 2017-12-31 | GBP 30.19bn | ifrs-full:Revenue |
| Cost of revenue | 12 months, 2017-01-01 to 2017-12-31 | GBP 10.34bn | ifrs-full:CostOfSales |
| Gross profit | 12 months, 2017-01-01 to 2017-12-31 | GBP 19.84bn | ifrs-full:GrossProfit |
| Operating income | 12 months, 2017-01-01 to 2017-12-31 | GBP 4.09bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2017-01-01 to 2017-12-31 | GBP 1.36bn | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2017-01-01 to 2017-12-31 | GBP 1.53bn | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2017-01-01 to 2017-12-31 | GBP 0.31 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2017-01-01 to 2017-12-31 | GBP 0.31 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2017-01-01 to 2017-12-31 | GBP 6.92bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2017-01-01 to 2017-12-31 | GBP 1.54bn | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2017-12-31 | GBP 3.83bn | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2017-12-31 | GBP 15.91bn | ifrs-full:CurrentAssets |
| Total assets | at 2017-12-31 | GBP 56.38bn | ifrs-full:Assets |
| Current liabilities | at 2017-12-31 | GBP 26.57bn | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2017-12-31 | GBP 52.89bn | ifrs-full:Liabilities |
| Shareholders' equity | at 2017-12-31 | −GBP 68.0m | ifrs-full:EquityAttributableToOwnersOfParent |
| Shares outstanding | at 2017-12-31 | 5,372,553,820 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1131399/000119312518088407/d516109d20fa.htm

Filed Mar 20, 2018.
Source: SEC EDGAR, the filing index for accession 0001193125-18-088407. Last ingested by Listed: Nov 14, 2026, 10:53 ET. No prices; not investment advice.
